|Tel||+44 (0)1865 234703|
Kanmin holds dual roles as the NIHR Academic Clinical Lecturer, conducting laboratory and clinical research within the Clinical Ophthalmology Research Group of Professor Robert MacLaren, and as the Senior Specialty Registrar at the Oxford Eye Hospital, working towards completion of ophthalmic specialty training. He conducted PhD research at the MRC Laboratory of Molecular Biology in Cambridge, underwent clinical training at Trinity College, Cambridge, and pre-clinical training at Brasenose College, Oxford, where he was awarded top-First Class (Martin Wronker Prize) in Medicine.
MA MB BChir PhD FRCOphth
Academic Clinical Lecturer in Ophthalmology
- Honorary Specialty Registrar, Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust
Kanmin's research focuses on the development of gene therapy as a treatment for inherited diseases of the retina. In association with Professor Robert MacLaren, he is leading the clinical trial of gene therapy for choroideremia, a model genetic disorder that causes progressive blindness. He is also investigating the cellular responses to gene therapy viral vectors within the retina with a view to producing more potent and sustained therapeutic effects.
Laurel Chandler, DPhil student (Merton College, Oxford)
Howell Fu, FHS student 2015 (Exeter College, Oxford)
Olivia Parham, FHS student 2016 (New College, Oxford)
Sharma SM. et al, (2017), Ophthalmol Ther
Edwards TL. et al, (2017), Ophthalmology
SUB-RETINAL CHIP IMPLANTATION TO PARTIALLY RESTORE VISION IN ADVANCED RETINITIS PIGMENTOSA: UPDATE FROM THE OXFORD RETINAL IMPLANT ALPHA AMS TRIAL
Edwards T. et al, (2017), CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 45, 29 - 30
Jolly JK. et al, (2017), Invest Ophthalmol Vis Sci, 58, 5575 - 5583
Xue K. et al, (2017), Eye (Lond), 31, 1308 - 1316